中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
WITEGAOP079氟苯尼考胺标准品 |
(1R,2S)-2-amino-3-fluoro-1-<4-(methylsulphonyl)phenyl>-1-propanol |
76639-93-5 |
C10H14FNO3S |
|
WHDS杂质1 |
3-(β-Aminoaethyl)-benzolsulfonamid |
81760-42-1 |
C8H12N2O2S |
|
WCK-5153R构型 |
(2S,5R)-7-oxo-6-sulphooxy-2-[N’-((R)-pyrrolidine-3-carbonyl)-hydrazinocarbonyl]-1,6-diaza-bicyclo[3.2.1]octane |
1452459-94-7 |
C12H19N5O7S |
|
WB 4101盐酸盐 |
2-(2,6-dimethoxyphenoxyethyl)aminoethyl-1,4-benzodioxane |
613-67-2 |
C19H23NO5 |
|
WAY629盐酸盐 |
1,2,3,4,8,9,10,11-Octahydro-<1,4>-diazepino<6,5,4-jk>carbazol |
57756-45-3 |
C15H18N2 |
|
WAY208466二盐酸盐 |
WAY-208466 |
633304-27-5 |
C17H18FN3O2S |
|
WAY 161503盐酸盐 |
8,9-dichloro-2,3,4,4a-tetrahydro-1H,6H-pyrazino[1,2-a]quinoxalin-5-one |
75704-24-4 |
C11H11Cl2N3O |
|
Voruciclib盐酸盐 |
(+)-trans-2-(2-chloro-4-trifluoromethylphenyl)-5,7-dihydroxy-8-(2-hydroxymethyl-1-methylpyrrolidin-3-yl)chromen-4-one hydrochloride |
1000023-05-1 |
C22H19ClF3NO5*ClH |
|
Vicriviroc苹果酸盐;1-[(4,6-二甲基-5-嘧啶基)羰基]-4-[(3S)-4-[(1R)-2-甲氧基-1-[4-(三氟甲基)苯基]乙基]-3-甲基-1-哌嗪基]-4-甲基哌啶苹果酸盐 |
1-[(4,6-Dimethyl-5-pyrimidinyl)carbonyl]-4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methyl-1-piperazinyl]-4-methylpiperidine malate |
541503-81-5 |
C32H44F3N5O7 |
|
Verucerfont; 3-(4-甲氧基-2-甲基苯基)-2,5-二甲基-N-[(1S)-1-(3-甲基-1,2,4-恶二唑-5-基)丙基]吡唑并[1,5-a]嘧啶-7-胺 |
Verucerfont |
885220-61-1 |
C22H26N6O2 |
|
Verdinexor(KPT-335)抑制剂 |
verdinexor |
1392136-43-4 |
C18H12F6N6O |
|
Val-cit-PAB-OH(VAL-CIT-PAB-羟基) |
(S)-2-((S)-2-amino-3-methylbutanamido)-N-(4-(hydroxymethyl)phenyl)-5-ureidopentanamide |
159857-79-1 |
C18H29N5O4 |
|
Val-Ala对硝基苯胺乙酸盐 |
Val-Ala p-Nitroanilide acetate salt |
108321-94-4 |
C16H24N4O6 |
|
VX-661中间体 |
(2R)-1-[5-amino-2-[1-(benzyloxy)-2-methylpropan-2-yl]6-fluoro-1H-indol-1-yl]-3-(benzyloxy)propan-2-ol |
1294504-67-8 |
C29H33FN2O3 |
|
VX-661/VX6611-(2,2-二氟-1,3-苯并二氧戊环-5-基)-N-[1-[(2R)-2,3-二羟基丙基]-6-氟-2-(2-羟基-1,1-二甲基乙基)-1H-吲哚-5-基]-环丙烷甲酰胺 |
(R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide |
1152311-62-0 |
C26H27F3N2O6 |
|
VUF11207三氟乙酸酯盐 |
VUF11207 |
1378524-41-4 |
C27H35FN2O4 |
|
VU590二盐酸盐 |
VU 590 dihydrochloride |
313505-85-0 |
C24H34Cl2N4O7 |
|
VU 0361737; N-(4-氯-3-甲氧基苯基)-2-吡啶甲酰胺 |
VU0361737 |
1161205-04-4 |
C13H11ClN2O2 |
|
VTP-27999 盐酸盐 |
VTP-27999 Hydrochloride |
—— |
C26H42Cl2N4O5 |
|
VP/甲基丙烯酸二甲氨基乙酯共聚物 |
2-(Dimethylamino)ethyl 2-methylprop-2-enoate;1-ethenylpyrrolidin-2-one |
160984-81-6 |
C14H24N2O3 |
|
VP/二十碳烯共聚物 |
1-ethenylpyrrolidin-2-one;icos-1-ene |
28211-18-9 |
C26H49NO |
|
VP/VAc共聚物 |
Pvp-VA |
25086-89-9 |
C10H15NO3 |
|
VP/DMAPA丙烯酸(酯)类共聚物 |
N-[3-(dimethylamino)propyl]-2-methylprop-2-enamide;1-ethenylpyrrolidin-2-one;sulfuric acid |
175893-71-7 |
C15H29N3O6S |
|
VE烟酸酯 |
alpha-tocopherol nicotinate |
51898-34-1 |
C35H53NO3 |
|
VER155008抑制剂 |
VER155008 |
1134156-31-2 |
C25H23Cl2N7O4 |
|
VELPATASVIR中间体 |
(3S,5S)-1-(tert-butoxycarbonyl)-5-(methoxycarbonyl)pyrrolidine-3-carboxylic acid |
1378388-35-2 |
C12H19NO6 |
|
VELPATASVIR 中间体 |
(2S,5S)-1-((S)-2-(methoxycarbonylamino)-3-methylbutanoyl)-5-methylpyrrolidine-2-carboxylic acid |
1335316-40-9 |
C13H22N2O5 |
|
VEL 0230 |
VEL-0230 |
221144-20-3 |
C14H24NO5*Na |
|
VEGFR2激酶抑制剂IV |
3-(thien-3-yl)-6-(4-methoxyphenyl)-pyrazolo(1,5-A)pyrimidine |
216661-57-3 |
C17H13N3OS |
|
VEGFR2激酶抑制剂II |
VEGF Receptor 2 Kinase Inhibitor II |
288144-20-7 |
C17H15BrN2O |
|
VECTOMER?4051乙烯醚 |
Bis[[4-(ethenoxymethyl)cyclohexyl]methyl] Benzene-1,4-dicarboxylate |
209072-72-0 |
C28H38O6 |
|
VCH-759(钠盐) |
Vch759;vch 759 |
1001913-13-8 |
C25H30NNaO4S |
|
V-9-M缩胆囊素九肽 |
Valyl-prolyl-valyl-glutamyl-alanyl-valyl-aspartyl-prolyl-methionine |
99291-20-0 |
C42H69N9O14S |
|
U型101017 |
tert-butyl 7-chloro-5-[(cis-3,5-dimethylpiperazino)carbonyl]imidazo[1,5-a]quinoline-3-carboxylate |
170568-47-5 |
C23H27ClN4O3 |
|
Uprosertib,GSK2141795抑制剂 |
N-{(1S)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-furancarboxamide |
1047634-65-0 |
C18H16Cl2F2N4O2 |
|
UmicoreM11催化剂 |
3-Phenyl-1H-inden-1-ylidene[bis(i-butylphobane)]ruthenium(II) dichloride |
894423-99-5 |
C39H56Cl2P2Ru |
|
UTP三钠盐 |
Uridine 5'-triphosphate tetrasodium |
14264-46-1 |
C9H11N2Na4O15P3 |
|
UTP:Α-D-葡萄糖-1-磷酸尿苷酰基转移酶 |
UTP---glucose-1-phosphate uridylyltransferase |
9026-22-6 |
—— |
——
|
USP杂质B |
fluconazole |
81886-51-3 |
C13H13FN6O |
|
UR-144N-(5-羟基戊基) |
(1-(5-hydroxypentyl)-1H-indol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone |
895155-95-0 |
C21H29NO2 |
|
UR-144N-(4-羟基戊基)代谢物 |
UR-144 N(4-hydroxypentyl) |
1537889-04-5 |
C21H29NO2 |
|
UMICOREM52催化剂 |
[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichloro[2-(2-oxopropoxy)phenyl]methyleneruthenium(II) |
1014701-61-1 |
C31H36Cl2N2O2Ru |
|
UMI-77抑制剂 |
UMI-77 |
518303-20-3 |
C18H14BrNO5S2 |
|
UK-148993,3羟基达非那新(非对映体混合物) |
2-[1-[2-(3-Hydroxy-2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide |
1285875-62-8 |
C28H30N2O3 |
|
UK 383367; 5-[(1R)-4-环己基-1-[2-(羟基氨基)-2-氧代乙基]丁基]-1,2,4-恶二唑-3-甲酰胺 |
UK-383367 |
348622-88-8 |
C15H24N4O4 |
|
UDP葡萄糖-4-差向异构酶 |
UDP-glucose 4-epimerase |
9032-89-7 |
—— |
——
|
UDP-葡萄醛酸三钠盐 |
UDP-glucuronic acid (trisodium) (Standard) |
—— |
C15H19N2Na3O18P2 |
|
UDP-N-乙酰半乳糖胺二钠盐 |
UDP-GlcNAc Disodium Salt |
91183-98-1 |
C17H25N3Na2O17P2 |
|
UDP-D-葡萄糖(钠盐) |
Uridine-dyphophate-glucose |
7333-33-7 |
C15H24N2NaO17P2+ |
|
U99194马来酸酯(PNU99194) |
U-99194 maleate |
234757-41-6 |
C21H31NO6 |
|